Profile data is unavailable for this security.
About the company
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Company’s CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
- Revenue in USD (TTM)127.76m
- Net income in USD-4.11m
- Incorporated1989
- Employees317.00
- LocationNatural Alternatives International Inc1535 Faraday AvenueCARLSBAD 92008United StatesUSA
- Phone+1 (760) 736-7700
- Fax+1 (760) 744-9589
- Websitehttps://www.nai-online.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuo Therapeutics Inc | 608.53k | -3.17m | 35.39m | -- | -- | 34.06 | -- | 58.16 | -0.0754 | -0.0754 | 0.0145 | 0.0235 | 0.2471 | 0.5609 | 3.55 | -- | -128.78 | -116.16 | -173.76 | -354.84 | 79.28 | 70.02 | -521.17 | -854.53 | 2.01 | -1,002.61 | 0.00 | -- | 442.12 | -14.99 | 0.0095 | -- | -- | -- |
| Vyne Therapeutics Inc | 424.00k | -27.87m | 35.67m | 10.00 | -- | 0.402 | -- | 84.13 | -6.84 | -7.00 | 0.0413 | 6.29 | 0.0061 | -- | 0.1639 | 42,400.00 | -40.27 | -108.41 | -45.86 | -138.57 | -- | -- | -6,573.82 | -1,907.10 | -- | -- | 0.00 | -- | -11.11 | -47.51 | 17.89 | -- | -- | -- |
| Promis Neurosciences Inc | 0.00 | -13.21m | 36.38m | 6.00 | -- | 9.65 | -- | -- | -1.22 | -1.22 | 0.00 | 0.1987 | 0.00 | -- | -- | 0.00 | -128.63 | -144.28 | -552.70 | -262.23 | -- | -- | -- | -2,271,047.00 | -- | -- | 0.00 | -- | -- | -- | 26.85 | -- | -- | -- |
| Marker Therapeutics Inc | 3.31m | -14.05m | 36.59m | 8.00 | -- | 2.60 | -- | 11.05 | -1.59 | -0.933 | 0.3753 | 1.58 | 0.1285 | -- | 1.93 | 413,892.50 | -54.49 | -53.74 | -69.03 | -62.25 | -- | -- | -424.20 | -1,438.71 | -- | -- | 0.00 | -- | -5.76 | 74.27 | 28.97 | -- | -- | -- |
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 36.80m | 1.00 | -- | 0.2055 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Apollomics Inc | 0.00 | -677.48k | 37.50m | -- | -- | 0.0448 | -- | -- | -0.0505 | -0.0505 | 0.00 | 9.36 | 0.00 | -- | -- | -- | -0.6357 | -- | -0.6538 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -281.92 | -- | -- | -- |
| SAB Biotherapeutics Inc | 2.24m | -42.19m | 37.82m | 57.00 | -- | 0.6601 | -- | 16.89 | -7.18 | -7.18 | 0.4056 | 6.21 | 0.0332 | -- | 0.8059 | 39,280.53 | -62.58 | -- | -77.39 | -- | -- | -- | -1,884.50 | -- | -- | -- | 0.0743 | -- | -90.63 | -- | -125.14 | -- | -- | -- |
| Natural Alternatives International, Inc. | 127.76m | -4.11m | 38.06m | 317.00 | -- | 0.4453 | 84.57 | 0.2979 | -0.705 | -0.705 | 21.87 | 14.03 | 0.8624 | 4.23 | 12.32 | 403,041.00 | -2.77 | 4.90 | -3.11 | 5.93 | 7.90 | 15.98 | -3.22 | 3.80 | 2.59 | -2.54 | 0.0988 | 0.00 | -9.91 | 3.06 | -76.46 | -20.74 | 27.08 | -- |
| NextCure Inc | 0.00 | -62.72m | 38.23m | 82.00 | -- | 0.3341 | -- | -- | -2.25 | -2.25 | 0.00 | 4.10 | 0.00 | -- | -- | 0.00 | -40.18 | -22.59 | -42.35 | -23.54 | -- | -- | -- | -964.96 | -- | -- | 0.00 | -- | -- | -- | 16.07 | -- | -23.17 | -- |
| Estrella Immunopharma Inc | 0.00 | -2.16m | 38.44m | -- | -- | 3.67 | -- | -- | -1.90 | -1.90 | 0.00 | 0.2861 | 0.00 | -- | -- | -- | -5.92 | -- | -7.86 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -302.11 | -- | -- | -- |
| ImmuCell Corp | 17.47m | -5.77m | 38.75m | 79.00 | -- | 1.55 | -- | 2.22 | -0.7454 | -0.7454 | 2.26 | 3.22 | 0.3941 | 1.96 | 8.86 | 221,160.40 | -13.03 | -5.16 | -14.19 | -5.53 | 22.15 | 40.04 | -33.05 | -12.64 | 0.8715 | -15.17 | 0.3238 | -- | -5.90 | 9.72 | -131.56 | -- | -1.39 | -- |
| Unicycive Therapeutics Inc | 675.00k | -31.41m | 39.45m | 14.00 | -- | -- | -- | 58.44 | -1.62 | -1.62 | 0.0276 | -0.1096 | 0.0794 | -- | -- | 48,214.29 | -359.15 | -218.20 | -- | -609.54 | -- | -- | -4,525.04 | -3,877.49 | -- | -- | -- | -- | -29.02 | -- | -73.95 | -- | -- | -- |
| Benson Hill Inc | 473.34m | -111.25m | 39.50m | 270.00 | -- | 0.4512 | -- | 0.0834 | -0.5914 | -0.6131 | 2.52 | 0.4129 | 1.22 | 10.27 | 14.81 | 1,753,096.00 | -28.68 | -- | -38.28 | -- | 4.99 | 3.18 | -23.50 | -40.73 | 0.9166 | -2.33 | 0.4509 | -- | 24.16 | 156.43 | -11.58 | -- | 63.78 | -- |
| Xilio Therapeutics Inc | 0.00 | -76.40m | 39.87m | 73.00 | -- | 0.8096 | -- | -- | -2.78 | -2.78 | 0.00 | 1.33 | 0.00 | -- | -- | 0.00 | -76.37 | -- | -93.74 | -- | -- | -- | -- | -- | -- | -131.89 | 0.0826 | -- | -- | -- | 13.40 | -- | -- | -- |
| Bright Green Corp | 0.00 | -13.13m | 41.19m | 5.00 | -- | 3.65 | -- | -- | -0.0732 | -0.0732 | 0.00 | 0.0594 | 0.00 | -- | -- | 0.00 | -64.24 | -- | -97.68 | -- | -- | -- | -- | -- | -- | -5,488.51 | 0.0181 | -- | -- | -- | 52.54 | -- | -- | -- |
Data as of May 01 2024. Currency figures normalised to Natural Alternatives International Inc's reporting currency: US Dollar USD
30.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Caldwell Sutter Capital, Inc. (Investment Management)as of 31 Mar 2024 | 444.34k | 7.30% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 440.28k | 7.23% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 338.06k | 5.55% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 240.24k | 3.95% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 169.38k | 2.78% |
| Bridgeway Capital Management LLCas of 31 Dec 2023 | 121.66k | 2.00% |
| Geode Capital Management LLCas of 31 Dec 2023 | 40.12k | 0.66% |
| RBC Global Asset Management (US), Inc.as of 31 Dec 2023 | 20.40k | 0.34% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 2023 | 20.15k | 0.33% |
| Liberty Wealth Management LLCas of 31 Dec 2023 | 19.66k | 0.32% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
